Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Anhui Anke Biotechnology

Explore full profile

Anhui Anke Biotechnology is a biopharmaceutical high-tech enterprise based in China

Hefei, ChinaFounded 1994Biotech & Life Sciences
Valuation $1.68B Market cap · Aug/2026
Revenue $389M Latest reported FY
EBITDA $135M Latest reported FY

At a glance

Status
Listed
Founded
1994
Headquarters
Hefei, China
Listing
IPO 2009
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Good Capital Group

Series B and later1 investor entered at this stage

  • Anhui Institute of Biology
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China94.7%
🇳🇿 New Zealand5.3%
2 countries shown
Web traffic by country
3.3K monthly visits
across markets
🇺🇸 United States63.6%
🇮🇳 India36.4%
Top 2 markets shown

Patents

Estimated portfolio value
$15M

234 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Anhui Anke Biotechnology was the backer or acquirer, 2017–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Anhui Anke Biotechnology's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Anhui Anke Biotechnology's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Anhui Anke Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Anhui Anke Biotechnology on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.